205 related articles for article (PubMed ID: 32320528)
1. Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.
Wei X; Valenzuela NM; Rossetti M; Sosa RA; Nevarez-Mejia J; Fishbein GA; Mulder A; Dhar J; Keslar KS; Baldwin WM; Fairchild RL; Hou J; Reed EF
Am J Transplant; 2020 Oct; 20(10):2686-2702. PubMed ID: 32320528
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy.
Nevarez-Mejia J; Jin YP; Pickering H; Parmar R; Valenzuela NM; Sosa RA; Heidt S; Fishbein GA; Rozengurt E; Baldwin WM; Fairchild RL; Reed EF
Am J Transplant; 2024 Mar; 24(3):406-418. PubMed ID: 38379280
[TBL] [Abstract][Full Text] [Related]
3. Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.
Salehi S; Sosa RA; Jin YP; Kageyama S; Fishbein MC; Rozengurt E; Kupiec-Weglinski JW; Reed EF
Am J Transplant; 2018 May; 18(5):1096-1109. PubMed ID: 29045076
[TBL] [Abstract][Full Text] [Related]
4. Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.
Valenzuela NM; Trinh KR; Mulder A; Morrison SL; Reed EF
Am J Transplant; 2015 Jun; 15(6):1502-18. PubMed ID: 25648976
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
[TBL] [Abstract][Full Text] [Related]
6. HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.
Valenzuela NM; Mulder A; Reed EF
J Immunol; 2013 Jun; 190(12):6635-50. PubMed ID: 23690477
[TBL] [Abstract][Full Text] [Related]
7. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
[TBL] [Abstract][Full Text] [Related]
8. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
[TBL] [Abstract][Full Text] [Related]
9. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
11. Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms.
Charreau B
Transplantation; 2021 Nov; 105(11):e156-e167. PubMed ID: 33724240
[TBL] [Abstract][Full Text] [Related]
12. Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation.
See SB; Mantell BS; Clerkin KJ; Ray B; Vasilescu ER; Marboe CC; Naka Y; Restaino S; Colombo PC; Addonizio LJ; Farr MA; Zorn E
Am J Transplant; 2020 Sep; 20(9):2571-2580. PubMed ID: 32190967
[TBL] [Abstract][Full Text] [Related]
13. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM
Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
[TBL] [Abstract][Full Text] [Related]
14. HLA class II antibody activation of endothelial cells induces M2 macrophage differentiation in peripheral blood.
Guo Y; Zheng B; Tian P; Zheng J; Li Y; Ding X; Xue W; Ding C
Clin Exp Nephrol; 2023 Apr; 27(4):309-320. PubMed ID: 36611129
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits donor-specific antibody production and attenuates mixed antibody-mediated renal allograft injury.
Zhao D; Li S; Liao T; Wei Y; Liu M; Han F; Luo Z; Liu X; Sun Q
Am J Transplant; 2018 May; 18(5):1083-1095. PubMed ID: 29178433
[TBL] [Abstract][Full Text] [Related]
16. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
18. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
19. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
